USE OF TGF-BETA ANTAGONISTS TO TREAT OR TO PREVENT CHRONIC TRANSPLANT REJECTION
申请(专利)号:
WO2003US01726
申请日期:
2003-01-21
公开/公告号:
WO03061587A2
公开/公告日期:
2003-07-31
申请(专利权)人:
GENZYME CORPORATION;UNIVERSITY HEALTH NETWORK;KESHAVJEE, SHAF;ST. GEORGE, JUDITH, A.;LIU, MINGYAO
被引量:
摘要:
Effective use of a TGF-β antagonist to treat or to prevent loss of transplant function is described herein. Use of a TGF-β antagonist is demonstrated to effectively prevent loss of organ function in a host due to chronic rejection in which TGF-β-mediated fibroproliferation is a characteristic. Expression in situ of a TGF-β antagonist in the form of a recombinant receptor, i.e., TGF-β type III receptor (TGFBIIIR) showed prevention of bronchiolitis obliterans in comparison to untreated controls in a rat lung transplant model. This provides an effective method for preventing or inhibiting chronic rejection of transplant organs such as lung, kidney, liver and hear in vertebrate hosts including human hosts.
展开
通过文献互助平台发起求助,成功后即可免费获取论文全文。
相似文献
参考文献
引证文献
引用走势
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用!